Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications

NCT00780403 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT00780403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00780403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications
Lead sponsor
Organon and Co
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2005
Completion date
October 31, 2005
Enrollment
220 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergies